Evaluation of Vestibular Stimulation to Help Occasional Sleeplessness
NCT00594022 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 349
Last updated 2019-01-07
Summary
The purpose of this study is to determine whether a small electrical current to the vestibular nerve (balance organ) will decrease the time it take for participants to fall asleep.
Conditions
- Insomnia
- Sleeplessness
- Transient Insomnia
Interventions
- DEVICE
-
Electric stimulation of the Vestibular Nerve - "VirtuSom"
This device is similar to a Tens or Micro-Current electrical stimulator with respect to current levels deliver; however, because of the location of the stimulation it is similar to a Cranial Electrical Stimulator. A small electric stimulation (100 uA - 1000 uA) will be provided at the mastoids (bi-laterally) via small hydrogel electrodes.
- DEVICE
-
Electric stim of the Vestibular Nerve - "VirtuSom" - SHAM
This device is similar to a Tens or Micro-Current electrical stimulator with respect to current levels deliver; however, because of the location of the stimulation it is similar to a Cranial Electrical Stimulator. For the Sham Group, NO electric stimulation (100 uA - 1000 uA) will be provided at the mastoids (bi-laterally) via small hydrogel electrodes. This is a sham / placebo device only.
Sponsors & Collaborators
-
Philips Respironics
lead INDUSTRY
Principal Investigators
-
Andrew Krystal · Duke University Medical Center, Duke Clinic Sleep Lab
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 21 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2007-10-31
- Primary Completion
- 2008-06-30
- Completion
- 2008-07-31
Countries
- United States
Study Locations
More Related Trials
-
Effect of Vestibular Stimulation on Sleep in Elderly
NCT03133442 ·Status: COMPLETED ·Phase: NA
-
VEC-162 Study in Adult Patients With Primary Insomnia
NCT00548340 ·Status: COMPLETED ·Phase: PHASE3
-
An Investigational Study to Assess Efficacy and Pattern of Use of SM-1 in Subjects With a History of Transient Insomnia
NCT03338764 ·Status: WITHDRAWN ·Phase: PHASE3
-
Study to Evaluate Armodafinil Treatment in Improving Prefrontal Cortical Activation and Working Memory Performance
NCT00711516 ·Status: COMPLETED ·Phase: PHASE4
-
Effects Of GW679769 On Sleep Onset And Maintenance And Next Day Functioning In Subjects With Primary Insomnia
NCT00280423 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate Safety, and Efficacy of SUVN-G3031 (Samelisant) in Patients With Narcolepsy With and Without Cataplexy
NCT04072380 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Compare the Awakening Threshold Effects of Belsomra 10 mg and 20 mg to Placebo in Non-elderly Insomniacs
NCT03312517 ·Status: COMPLETED ·Phase: PHASE4
-
Performance Evaluation of the Dreem 3 System for Sleep Assessment in Patients With Insomnia
NCT05438017 ·Status: COMPLETED ·Phase: NA
-
Remote Ischemic Conditioning for the Treatment of Stroke-related Insomnia
NCT05289518 ·Status: UNKNOWN ·Phase: NA
-
Sleep Efficacy Randomized Evaluation of a Novel Digital Therapeutic for Insomnia
NCT07295431 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
SM-1 vs 2 Comparators and Placebo in Participants With a History of Transient Insomnia.
NCT03331042 ·Status: COMPLETED ·Phase: PHASE3
-
Trial Comparing Effects of Xyrem Taken Orally and Modafinil With Placebo in Treating Daytime Sleepiness in Narcolepsy
NCT00066170 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Safety of Gabapentin in a Potential Over-the-Counter Population With Occasional Sleeplessness
NCT00666575 ·Status: COMPLETED ·Phase: PHASE3
-
Modafinil Versus Amphetamines for the Treatment of Narcolepsy Type 2 and Idiopathic Hypersomnia
NCT03772314 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy, Safety and Tolerability of Sulthiame in Patients With Obstructive Sleep Apnea (OSA)
NCT05236842 ·Status: COMPLETED ·Phase: PHASE2
-
Vestipitant 28-day Tolerance Study
NCT00992160 ·Status: COMPLETED ·Phase: PHASE2
-
Slow Wave Induction by Propofol to Eliminate Depression (SWIPED) Stage II
NCT06867549 ·Status: RECRUITING ·Phase: PHASE2
-
Efficacy Study of EVT 201 to Treat Insomnia
NCT00380003 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Efficacy and Safety of Armodafinil as Treatment for Patients With Excessive Sleepiness Associated With Mild or Moderate Closed Traumatic Brain Injury
NCT00893789 ·Status: TERMINATED ·Phase: PHASE3
-
An Exploratory Study of NBI-34060 Capsules and Next Day Functioning
NCT00525941 ·Status: WITHDRAWN ·Phase: PHASE3
-
Armodafinil (CEP-10953) for Treatment of Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, or Chronic Shift Work Sleep Disorder
NCT00078312 ·Status: COMPLETED ·Phase: PHASE3
-
Sleepiness and Brain Function: The Effect of Armodafinil in Shift Work Sleep Disorder
NCT00688142 ·Status: COMPLETED
-
A Study With GW597599 And GR205171: Potential New Drugs For The Treatment Of Primary Insomnia
NCT00606697 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of LY3154207 on Sleep in Healthy Male Participants
NCT02603861 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of LY2624803 in Japanese Participants With Transient Insomnia
NCT01784614 ·Status: COMPLETED ·Phase: PHASE1